Allworth Financial LP Acquires 3,694 Shares of Colgate-Palmolive (NYSE:CL)

Allworth Financial LP lifted its position in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 20.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 21,584 shares of the company's stock after purchasing an additional 3,694 shares during the quarter. Allworth Financial LP's holdings in Colgate-Palmolive were worth $1,890,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. D Orazio & Associates Inc. raised its stake in shares of Colgate-Palmolive by 3.9% during the third quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company's stock valued at $297,000 after acquiring an additional 108 shares during the last quarter. Fiducient Advisors LLC raised its stake in shares of Colgate-Palmolive by 5.2% during the third quarter. Fiducient Advisors LLC now owns 2,231 shares of the company's stock valued at $232,000 after acquiring an additional 110 shares during the last quarter. Sequoia Financial Advisors LLC raised its stake in shares of Colgate-Palmolive by 0.6% during the third quarter. Sequoia Financial Advisors LLC now owns 20,392 shares of the company's stock valued at $2,117,000 after acquiring an additional 113 shares during the last quarter. Waldron Private Wealth LLC raised its stake in shares of Colgate-Palmolive by 2.1% during the third quarter. Waldron Private Wealth LLC now owns 5,632 shares of the company's stock valued at $585,000 after acquiring an additional 118 shares during the last quarter. Finally, Commonwealth Financial Services LLC raised its stake in shares of Colgate-Palmolive by 4.5% during the fourth quarter. Commonwealth Financial Services LLC now owns 2,716 shares of the company's stock valued at $247,000 after acquiring an additional 118 shares during the last quarter. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Stock Up 1.9 %

Colgate-Palmolive stock traded up $1.69 during midday trading on Friday, hitting $89.56. 4,747,229 shares of the stock were exchanged, compared to its average volume of 4,884,892. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. The stock has a market capitalization of $72.68 billion, a price-to-earnings ratio of 25.44, a price-to-earnings-growth ratio of 4.18 and a beta of 0.44. Colgate-Palmolive has a 52-week low of $84.45 and a 52-week high of $109.30. The business's 50-day moving average price is $89.02 and its 200-day moving average price is $95.99.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating analysts' consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the previous year, the business earned $0.87 EPS. On average, research analysts expect that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st were paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 2.23%. The ex-dividend date was Tuesday, January 21st. Colgate-Palmolive's payout ratio is 56.82%.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the stock. StockNews.com downgraded shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a research note on Thursday, January 9th. Stifel Nicolaus decreased their price target on shares of Colgate-Palmolive from $95.00 to $93.00 and set a "hold" rating for the company in a research note on Monday, February 3rd. UBS Group decreased their price target on shares of Colgate-Palmolive from $104.00 to $100.00 and set a "buy" rating for the company in a research note on Monday, February 3rd. Wells Fargo & Company decreased their price target on shares of Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating for the company in a research note on Tuesday, January 7th. Finally, Raymond James reaffirmed an "outperform" rating and issued a $105.00 price target (down from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat.com, Colgate-Palmolive has an average rating of "Hold" and an average target price of $101.16.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.